期刊
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
卷 46, 期 8, 页码 1705-1709出版社
SPRINGER
DOI: 10.1007/s40618-023-02031-5
关键词
AIP; Acromegaly; Colorectal cancer; Familial; Gene; GH; Growth hormone; Mutation; Pituitary adenoma; Twins
This study reports a novel AIP mutation in a German family with acromegaly. It highlights the distinct clinical and histological features of AIP mutated pituitary neuroendocrine tumors and the poor responsiveness to dopamine agonists. Additionally, it emphasizes the increased mortality risk of comorbidities associated with acromegaly.
The most frequent genetic alteration of familial isolated growth hormone producing pituitary neuroendocrine tumors is a germline mutation of the aryl hydrocarbon receptor-interacting protein (AIP) gene. Various AIP mutations are already known; however, an AIP mutation in exon 6 (c.811_812del; p.Arg271Glyfs*16) has not been reported yet. Here, we report a German family with two identical twins who were both affected by acromegaly and carried the above-mentioned novel AIP mutation. The father was found to be an unaffected carrier, while the paternal aunt most likely suffered from acromegaly as well and died from metastatic colorectal cancer. Apart from reporting a novel AIP mutation, this study does not only highlight the different clinical and histological features of the AIP mutated growth hormone producing pituitary neuroendocrine tumors but also confirms the poor responsiveness of dopamine agonists in AIP mutated acromegaly. Furthermore, it highlights the increased mortality risk of comorbidities typically associated with acromegaly.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据